Found: 47
Select item for more details and to access through your institution.
Asprosin-neutralizing antibodies as a treatment for metabolic syndrome.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.63784
- By:
- Publication type:
- Article
Blocking LAIR1 signaling in immune cells inhibits tumor development.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.996026
- By:
- Publication type:
- Article
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23793-7
- By:
- Publication type:
- Article
Presence of complete murine viral genome sequences in patient-derived xenografts.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22200-5
- By:
- Publication type:
- Article
Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies.
- Published in:
- Biologics: Targets & Therapy, 2010, v. 4, p. 163
- By:
- Publication type:
- Article
Neural Differentiation of Mouse Neural Stem Cells as a Tool to Assess Developmental Neurotoxicity of Drinking Water in Taihu Lake.
- Published in:
- Biological Trace Element Research, 2019, v. 190, n. 1, p. 172, doi. 10.1007/s12011-018-1533-5
- By:
- Publication type:
- Article
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0038-0
- By:
- Publication type:
- Article
Antibody therapies for the prevention and treatment of viral infections.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0019-3
- By:
- Publication type:
- Article
Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009094
- By:
- Publication type:
- Article
281 Fc gamma receptor crosslinking promotes antibody-induced LILRB4 internalization and immune regulation of acute monocytic leukemia.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.68571
- By:
- Publication type:
- Article
Leukocyte immunoglobulin‐like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 4, p. 476, doi. 10.1002/cyto.b.21952
- By:
- Publication type:
- Article
Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 6, p. 1, doi. 10.1371/journal.ppat.1007716
- By:
- Publication type:
- Article
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00593-y
- By:
- Publication type:
- Article
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00860-w
- By:
- Publication type:
- Article
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00749-0
- By:
- Publication type:
- Article
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00749-0
- By:
- Publication type:
- Article
Human Endogenous Retroviruses in Glioblastoma Multiforme.
- Published in:
- Microorganisms, 2021, v. 9, n. 4, p. 764, doi. 10.3390/microorganisms9040764
- By:
- Publication type:
- Article
Virome assembly and annotation in brain tissue based on next‐generation sequencing.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6776, doi. 10.1002/cam4.3325
- By:
- Publication type:
- Article
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction.
- Published in:
- Nature Communications, 2014, v. 5, n. 3, p. 3485, doi. 10.1038/ncomms4485
- By:
- Publication type:
- Article
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 5, p. 697, doi. 10.3390/v16050697
- By:
- Publication type:
- Article
HER3/ErbB3, an emerging cancer therapeutic target.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2016, v. 48, n. 1, p. 39, doi. 10.1093/abbs/gmv103
- By:
- Publication type:
- Article
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML.
- Published in:
- Antibody Therapeutics, 2024, v. 7, n. 1, p. 13, doi. 10.1093/abt/tbad025
- By:
- Publication type:
- Article
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in mice.
- Published in:
- Antibody Therapeutics, 2023, v. 6, n. 1, p. 1, doi. 10.1093/abt/tbac027
- By:
- Publication type:
- Article
Engineering antibody and protein therapeutics to cross the blood–brain barrier.
- Published in:
- Antibody Therapeutics, 2022, v. 5, n. 4, p. 311, doi. 10.1093/abt/tbac028
- By:
- Publication type:
- Article
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.
- Published in:
- Antibody Therapeutics, 2021, v. 4, n. 4, p. 16, doi. 10.1093/abt/tbab002
- By:
- Publication type:
- Article
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.
- Published in:
- Antibody Therapeutics, 2021, v. 4, n. 1, p. 16, doi. 10.1093/abt/tbab002
- By:
- Publication type:
- Article
Antibody therapies for the treatment of COVID-19.
- Published in:
- Antibody Therapeutics, 2020, v. 3, n. 2, p. 101, doi. 10.1093/abt/tbaa007
- By:
- Publication type:
- Article
T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteins.
- Published in:
- Antibody Therapeutics, 2019, v. 2, n. 1, p. 22, doi. 10.1093/abt/tbz001
- By:
- Publication type:
- Article
2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective.
- Published in:
- Antibody Therapeutics, 2019, v. 2, n. 1, p. 40, doi. 10.1093/abt/tbz003
- By:
- Publication type:
- Article
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00342-3
- By:
- Publication type:
- Article
Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04982-3
- By:
- Publication type:
- Article
Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277956
- By:
- Publication type:
- Article
Isolation and characterization of IgG1 with asymmetrical Fc glycosylation.
- Published in:
- Glycobiology, 2011, v. 21, n. 8, p. 1087
- By:
- Publication type:
- Article
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 661, p. 1, doi. 10.1126/scitranslmed.abq0095
- By:
- Publication type:
- Article
HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways.
- Published in:
- Protein & Cell, 2012, v. 3, n. 10, p. 781, doi. 10.1007/s13238-012-2065-y
- By:
- Publication type:
- Article
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 8, p. 1, doi. 10.1371/journal.ppat.1008736
- By:
- Publication type:
- Article
Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 7, p. 1, doi. 10.1371/journal.ppat.1007914
- By:
- Publication type:
- Article
Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03931-7
- By:
- Publication type:
- Article
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20789-7
- By:
- Publication type:
- Article
LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-022-00550-y
- By:
- Publication type:
- Article
Improved activity and thermostability of Candida antarctica lipase B by DNA family shuffling.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2004, v. 17, n. 2, p. 133, doi. 10.1093/protein/gzh017
- By:
- Publication type:
- Article
92-OR: Using Bispecific Monoclonal Antibody to Reprogram the Development of Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-92-OR
- By:
- Publication type:
- Article